(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC

NCT04777981 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SAR

Interventions

DIETARY_SUPPLEMENT: CBDRA60 supplement
DIETARY_SUPPLEMENT: Placebo

Sponsor

Anewsha Therapeutics Inc.

Collaborators

[object Object]
[object Object]